Please select the eligibility criteria that correspond to the clinical trial below.
Title: A Randomized Clinical Trial of Treatment for Mild Gestational Diabetes Mellitus
Brief Summary: Gestational diabetes mellitus (GDM) is a type of diabetes (high blood sugar) that occurs in pregnant women. This study will determine whether treating pregnant women who have mild GDM improves the health of their babies. The follow-up study will examine whether factors during the previous pregnancy (such as blood sugar during pregnancy) are associated with the woman and her child's health 4-9 years later.


Options:
A: Inclusion Criteria:

* Pregnant women with an abnormal 75 gram 2 hour glucose tolerance test as defined by the IADPSG (International Association of Diabetes in Pregnancy Study Group)
* Willingness and able to give informed consent
* Female aged between 18-40 years
* Singleton pregnancy
* Able to travel to hospital independently

Exclusion Criteria:

* Impaired cognitive function such that she is unable to operate m-health equipment
* Any evidence of fetal compromise
* Known risk factors for obstetric complications, other than obesity and diabetes
* Gestational diabetes requiring immediate pharmacologic treatment
* Twins or higher order pregnancy
* OGTT (Oral Glucose Tolerance Test) suggesting preexisting diabetes (fasting blood glucose \>= 7.0 or 2 hour \>= 11.1 mmol/L
* Gestation greater than 34+6 at the time of potential recruitment
* Unable to speak English well enough to explain or use equipment
B: Inclusion Criteria:

* Pregnant
* Gestational age at enrollment 24 - 31 weeks

Exclusion Criteria:

* Diabetes diagnosed prior to pregnancy
* Abnormal gestational diabetes (\>= 135 mg/dl) testing prior to 24 weeks' gestation
* Gestational diabetes in a previous pregnancy
* History of stillbirth or fetal death
* Pregnancy with more than one fetus
* Known major fetal anomaly
* Current or planned corticosteroid therapy
* Asthma requiring medication
* Current or planned beta adrenergic therapy
* Chronic hypertension requiring medication within 6 months of or during pregnancy
* Chronic medical conditions such as HIV/AIDS, kidney disease, or congenital heart disease
* Hematologic or autoimmune disease such as sickle cell disease, other hemoglobinopathies, lupus, or antiphospholipid syndrome
* Maternal or fetal conditions likely to require preterm delivery, such as pre-eclampsia, preterm labor, or intrauterine growth retardation
* Previous or planned tocolytic therapy to induce labor or increase contraction strength
C: Inclusion Criteria:

* Pregnant
* Gestational Diabetes or IGT following an oral glucose tolerance test performed at the 24-28 week screening appointment
* Able to use the telehealth equipment following training by staff from the company providing telehealth services
* Have sufficient communication skills \[hearing, speech \& language\] to be fully involved.
* Willing to use one of the approved blood glucose meters for self monitoring of blood glucose, for the duration of the study.

Exclusion Criteria:

* Previously diagnosed Type 1 diabetes or Type 2 diabetes as evidenced by medical records.
* Other diagnosed medical problems or medical therapy such as steroid therapy that would influence blood glucose control and to be decided by the endocrinologist prior to recruitment. Such exclusions to be noted by the endocrinologist or diabetes nurse specialist.
* Previous gestational diabetes is not an exclusion criterion.
D: Inclusion Criteria:

* Framingham risk score equal to or greater than 10%
* literacy
* 22 -85 years of age
* access to phone

  * ability to use Internet and system following training

Exclusion Criteria:

* Class 3 and 4 heart failure
* ESRD
* stroke with residual disability or dementia
* unable to read or write

Answer: B